Wynnefield Partners Small Cap Value LP's Form 4 filing
Lifecore Biomedical, Inc. DE (LFCR) · filed Jan 14, 2022
- Accession no.
- 0001104659-22-004450
- Filed
- Jan 14, 2022, 4:46 PM ET
- Trade date
- Jan 12-13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.03M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wynnefield Partners Small Cap Value LPCIK 0000899083 | 10% Owner |
| Obus NelsonCIK 0001017043 | 10% Owner |
| Wynnefield Small Cap Value Offshore Fund LtdCIK 0001030806 | 10% Owner |
| Wynnefield Capital Management LLCCIK 0001056835 | 10% Owner |
| Wynnefield Partners Small Cap Value LP ICIK 0001251565 | 10% Owner |
| Wynnefield Capital IncCIK 0001251567 | 10% Owner |
| Landes JoshuaCIK 0001251568 | 10% Owner |
| Wynnefield Capital, Inc. Profit Sharing PlanCIK 0001289453 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +90,128 | $10.41 | +$937,962.1 | 1,490,473 | Direct | |
| Jan 12, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +209,872 | $10.41 | +$2,184,137.9 | 1,955,414 | Indirect | |
| Jan 13, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +19,520 | $10.41 | +$203,105.6 | 1,509,993 | Direct | |
| Jan 13, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +30,480 | $10.41 | +$317,144.4 | 1,985,894 | Indirect | |
| Jan 13, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +14,600 | $10.43 | +$152,205 | 1,524,593 | Direct | |
| Jan 13, 2022 | Common Stock, $0.001 par value per share | PPurchaseAcquired | +22,800 | $10.43 | +$237,690 | 2,008,694 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.